TW255886B - - Google Patents

Info

Publication number
TW255886B
TW255886B TW083103432A TW83103432A TW255886B TW 255886 B TW255886 B TW 255886B TW 083103432 A TW083103432 A TW 083103432A TW 83103432 A TW83103432 A TW 83103432A TW 255886 B TW255886 B TW 255886B
Authority
TW
Taiwan
Prior art keywords
compound
general formula
lower alkyl
cycloalkyl
alkyl
Prior art date
Application number
TW083103432A
Other languages
English (en)
Chinese (zh)
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of TW255886B publication Critical patent/TW255886B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
TW083103432A 1993-04-16 1994-04-18 TW255886B (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8994493 1993-04-16

Publications (1)

Publication Number Publication Date
TW255886B true TW255886B (cg-RX-API-DMAC10.html) 1995-09-01

Family

ID=13984820

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083103432A TW255886B (cg-RX-API-DMAC10.html) 1993-04-16 1994-04-18

Country Status (13)

Country Link
US (1) US5488134A (cg-RX-API-DMAC10.html)
EP (1) EP0646570B1 (cg-RX-API-DMAC10.html)
JP (1) JP3411036B2 (cg-RX-API-DMAC10.html)
KR (1) KR100277242B1 (cg-RX-API-DMAC10.html)
CN (1) CN1046937C (cg-RX-API-DMAC10.html)
AT (1) ATE167662T1 (cg-RX-API-DMAC10.html)
AU (1) AU666819B2 (cg-RX-API-DMAC10.html)
CA (1) CA2138264C (cg-RX-API-DMAC10.html)
DE (1) DE69411243T2 (cg-RX-API-DMAC10.html)
DK (1) DK0646570T3 (cg-RX-API-DMAC10.html)
ES (1) ES2119190T3 (cg-RX-API-DMAC10.html)
TW (1) TW255886B (cg-RX-API-DMAC10.html)
WO (1) WO1994024087A1 (cg-RX-API-DMAC10.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2121060C (en) * 1993-04-16 2004-04-06 Sachio Mori Preparation of lignan analogues
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
KR100376281B1 (ko) * 1995-12-26 2003-09-26 에스케이케미칼주식회사 리그난의 제조방법
EP1026167B1 (en) 1997-09-29 2003-03-05 Meiji Seika Kaisha Ltd. Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents
WO2000038721A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
DE69908644T2 (de) 1998-12-23 2004-05-13 G.D. Searle Llc, Chicago Kombnationen von cholesteryl ester transfer protein inhibitoren und gallensäure sequestriermitteln für kardiovaskuläre indikationen
PT1140188E (pt) 1998-12-23 2003-10-31 Searle Llc Combinacoes de inibidores do transporte de acidos biliares do ileo e de inibidores da proteina de transferencia de esteres de colesterilo para doencas cardiovasculares.
WO2000038722A1 (en) 1998-12-23 2000-07-06 G.D. Searle & Co. COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS
US6562860B1 (en) 1998-12-23 2003-05-13 G. D. Searle & Co. Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
MXPA01006472A (es) 1998-12-23 2004-03-10 Searle Llc Combinaciones de inhibidores de transporte de acido biliar ileal y derivados de acido fibrico para indicaciones cardiovasculares.
AU776664B2 (en) 1998-12-23 2004-09-16 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
WO2001068096A2 (en) * 2000-03-10 2001-09-20 Pharmacia Corporation Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
HK1052183A1 (zh) 2000-03-10 2003-09-05 Pharmacia Corporation 制造tetrahydrobenzothiepines的方法
US6740663B2 (en) 2001-11-02 2004-05-25 G.D. Searle, Llc Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
WO2003061604A2 (en) 2002-01-17 2003-07-31 Pharmacia Corporation Novel alkyl/aryl hydroxy or keto thiepines.
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
EP2575821B1 (en) 2010-05-26 2015-08-12 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
CA2852957C (en) 2011-10-28 2020-08-04 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
JP6217938B2 (ja) 2011-10-28 2017-10-25 ルメナ ファーマシューティカルズ エルエルシー 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤
EP2968262A1 (en) 2013-03-15 2016-01-20 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease
WO2014144650A2 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
BR112021015815A2 (pt) 2019-02-12 2022-01-18 Mirum Pharmaceuticals Inc Métodos para tratar colestase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0372422A (ja) * 1989-05-16 1991-03-27 Tanabe Seiyaku Co Ltd 抗脂血剤
JPH03157351A (ja) * 1989-11-13 1991-07-05 Tanabe Seiyaku Co Ltd ナフタレン誘導体及びその製法
DK0597107T3 (da) * 1991-10-17 1996-07-29 Shionogi & Co Lignananalog, fremstilling deraf og hypolipidæmisk medikament

Also Published As

Publication number Publication date
EP0646570A4 (en) 1995-08-09
JP3411036B2 (ja) 2003-05-26
CA2138264C (en) 2004-04-06
ATE167662T1 (de) 1998-07-15
DK0646570T3 (da) 1998-10-26
DE69411243D1 (de) 1998-07-30
AU666819B2 (en) 1996-02-22
CN1046937C (zh) 1999-12-01
KR950701902A (ko) 1995-05-17
US5488134A (en) 1996-01-30
WO1994024087A1 (fr) 1994-10-27
CN1109685A (zh) 1995-10-04
DE69411243T2 (de) 1998-11-19
EP0646570A1 (en) 1995-04-05
AU6437994A (en) 1994-11-08
CA2138264A1 (en) 1994-10-27
EP0646570B1 (en) 1998-06-24
KR100277242B1 (ko) 2001-02-01
ES2119190T3 (es) 1998-10-01

Similar Documents

Publication Publication Date Title
TW255886B (cg-RX-API-DMAC10.html)
AU4497993A (en) Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
TW223645B (cg-RX-API-DMAC10.html)
EP0405864A3 (en) Phospholipase a2 inhibitor, microorganisms producing said inhibitor and processes for its production
AU1120095A (en) Novel imidazole derivative and process for producing the same
EP0554455A4 (cg-RX-API-DMAC10.html)
AU2722095A (en) Novel pyrrolocarbazoles
EP0712843A4 (en) VITAMIN D3 DERIVATIVE AND PROCESS FOR PRODUCING THE SAME
HRP931292B1 (en) Carbazolone derivatives and the process for preparing the same
GR3006060T3 (cg-RX-API-DMAC10.html)
AU8460791A (en) Compound, preparation and use
EP0601191A4 (en) Novel tetracyclic compound.
AU2406097A (en) Process for the preparation of tetrahydro-indolizines
HU9602789D0 (en) Method for preparing alpha, beta-unsaturated-beta-trifluoromethyl carboxylates and related compounds
GR3032474T3 (en) Selective dehalogenation method
AU8452591A (en) 2-thio-1-aminocarbonyl cyclo alk-1-enes
EP0331073A3 (en) Benzhydrylamine derivatives
GR3034291T3 (en) Catalyst with improved activity for ethylene (co)-polymerization
AU2474488A (en) Photochromatic composition and photochromatic articles which contain it
GR3004216T3 (cg-RX-API-DMAC10.html)
MX9800041A (es) Procedimiento mejorado para sintetizar intermediarios de carbapenem.
MX9800042A (es) Metodos, composiciones, y/o articulos de limpieza/saneamiento, para superficies inanimadas no alimenticias.
HUT47929A (en) Process for producing 4-piperidine-carboxamide derivatives and pharmaceuticals comprising same
GR3021427T3 (en) Indole derivative
EP0974572A4 (en) NEW PROCESS FOR THE PRODUCTION OF ALCOHOLS

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees